The Company has applied ASBJ Statement No. 29 “Accounting Standard for Revenue Recognition”, etc. from the beginning of 2021 fiscal year. The figures for the fiscal year ended Mar 31, 2022 represent amounts after the application of the said accounting standard, etc.​

Results

(Millions of yen)
FY2019 FY2020 FY2021 FY2022 FY2023
Net Sales 105,477 97,266 88,084 104,208 94,557
Operating Income 9,698 8,341 12,401 15,557 10,492
Ordinary Income 10,321 8,838 13,435 17,164 12,008
Net Income 6,506 6,050 9,442 10,570 7,650

Per share data

(yen)
FY2019 FY2020 FY2021 FY2022 FY2023
Earnings per share 276.14 257.37 404.73 428.43 300.84
Net assets per share 2,912.98 3,310.56 3,594.69 3,912.48 4,325.88
Dividend per share 65.0 65.0 80.0 90.0 90.0

Assets and Ｌiabilities

FY2019 FY2020 FY2021 FY2022 FY2022
Total Assets (Millions of yen) 110,851 119,373 129,159 138,029 150,541
Net Assets(Millions of yen) 69,121 77,232 83,896 99,543 109,765
Shareholder’s equity ratio (%) 62.4 64.7 64.9 72.1 72.9
Interest-bearing debt
(Millions of yen)		 17,767 15,909 15,905 7,664 7,630
D/E ratio (times) 0.3 0.2 0.2 0.1 0.1

Management index

FY2019 FY2020 FY2021 FY2022 FY2023
Return on equity [ROE] (%) 9.7 8.3 11.7 11.5 7.3
Return on assets [ROA] (%) 9.2 7.7 10.8 12.8 8.3
Price earnings ratio [PER] (times) 9.3 10.2 7.7 10.2 32.1
Capital expenditures
(Millions of yen)		 3,840 2,388 6,790 5,353 7,190
Depreciation (Millions of yen) 3,626 3,894 3,731 3,635 3,684
Research and development expenses
(Millions of yen)		 2,187 2,201 2,344 2,589 2,817

Cash flows

(Millions of yen)
FY2019 FY2020 FY2021 FY2022 FY2023
Cash flows from operating
activities		 10,336 9,347 13,378 9,354 8,597
Cash flows from investing
activities		 -4,092 -1,850 -6,961 -5,380 -4,263
Cash flows from financing
activities		 -1,677 -4,464 -1,646 -4,596 -3,199
Cash and cash equivalents at
the end of fiscal year		 28,899 31,936 37,016 36,843 38,432

Segment Information

The Company has changed the business segment from the fiscal year ending March 31, 2024. Figures for the fiscal year ended March 31, 2022 and the fiscal year ending March 31, 2023 are approximate figures that have been reclassified to the new segments.

Basic Chemicals

(Millions of yen)
FY2021 FY2022 FY2023
Net Sales 34,939 42,322 36,272
Operating Income 4,688 4,847 231

Functional Chemicals

(Millions of yen)
FY2021 FY2022 FY2023
Net Sales 25,735 31,859 29,133
Operating Income 4,714 6,398 4,544

Healthcare

(Millions of yen)
FY2021 FY2022 FY2023
Net Sales 8,224 10,275 11,868
Operating Income 3,375 4,615 5,715

Trading and others

(Millions of yen)
FY2021 FY2022 FY2023
Net Sales 19,186 19,750 17,283
Operating Income 812 988 1,217